You are here: Industry Insights > Variants

News List

Pharma Sources Insight April 2022: An Overview on BIopharma and API in China and the World Pharma Sources Insight
March 29, 2022
Pharma Sources Insight APRIL 2022 focuses on the universal COVID-19 vaccine, Chinese API, pharma packaging, global biopharma trends and more.
Needle free COVID-19 vaccine trialled in UK PharmaTimes
December 16, 2021
The DIOSvax technology produced by the University of Southampton aims to predict how the virus could mutate.
Burden of Rare Genetic Variants Higher in Severe Schizophrenia Drugs
December 14, 2021
Individuals with severe, extremely treatment-resistant schizophrenia have an increased burden of high-impact rare genetic variants, according to a study published in the Dec. 21 issue...
At-Home Saliva Test Can Spot COVID Variants drugs
August 09, 2021
Spit and scan. That's all you have to do, and in less than an hour, you can not only find out if you have COVID-19 but what variant you have, all without leaving your home.
AZ says its COVID-19 vaccine protects against severe disease caused by variants pharmatimes
July 26, 2021
AstraZeneca (AZ) has announced that new real-world data from Canada shows its COVID-19 vaccine – Vaxzevria – was found to be highly effective after one dose against severe disease or hospitalisation caused by the Beta and Delta variants.
Researchers develop COVID-19 antibody test to detect new variants pharmatimes
June 18, 2021
New antibody tests that can detect if an individual has been exposed to COVID-19 variants have been developed by scientists from the University of Aberdeen.
Comirnaty® COVID-19 vaccine protects against multiple viral variants europeanpharmaceuticalreview
June 16, 2021
Laboratory study shows the blood sera of people vaccinated against COVID-19 with Comirnaty® can neutralise at least six viral variants including three variants of concern.
Scientists identify drug that prevents multiple coronavirus variants expresspharma
June 01, 2021
Scientists have identified a new drug which is highly effective in preventing severe COVID-19 in mice infected with SARS-CoV-2, and could also treat other respiratory coronaviruses.
Oxford University and Oracle Partner to Speed Identification of COVID-19 Variants americanpharmaceuticalreview
May 18, 2021
The emergence of more infectious variants of the COVID-19 virus is threatening to slow the global recovery and potentially thwart current vaccine immunity.
Our immune systems blanket the SARS-CoV-2 spike protein with antibodies worldpharmanews
May 11, 2021
The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at ...

Previous page 1 2 Next page